P519. Efficacy and safety of biosimilar of infliximab (Inflectra) in adult patients with Crohn’s disease during 1 year of treatment, followed 6 months of observation: a one-centre retrospective study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.